Retatrutide and the Next Generation of Multi-Receptor Metabolic Peptides
Retatrutide and the Next Generation of Multi-Receptor Metabolic Peptides The success of GLP-1 receptor agonists such as semaglutide and the dual GIP/GLP-1 agonist tirzepatide has changed metabolic peptide research. Researchers now study peptides that can target several receptors at the same time. Retatrutide stands out as a triple agonist that targets the GLP-1, GIP, and … Read more